5-LO and particularly the 12/15-LO-derived LM can act as agonists of the peroxisome proliferator-activated receptor-γ (PPARγ)22,23, a transcription factor with relevance to the pathogenesis of MS and exhibiting potential as a therapeutic target. Here, PPARG is linked to myeloid sarcoma.